ChemoMetec Ownership

CHY Stock  EUR 69.25  2.30  3.44%   
ChemoMetec holds a total of 17.4 Million outstanding shares. Over half of ChemoMetec's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in ChemoMetec. Please watch out for any change in the institutional holdings of ChemoMetec AS as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ChemoMetec AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

ChemoMetec Stock Ownership Analysis

About 51.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 221.15. ChemoMetec AS last dividend was issued on the 9th of October 2020. ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis in Denmark, the United States, Canada, rest of Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. CHEMOMETEC operates under Scientific Technical Instruments classification in Germany and is traded on Frankfurt Stock Exchange. It employs 147 people. For more info on ChemoMetec AS please contact the company at 45 48 13 10 20 or go to https://chemometec.com.

ChemoMetec Outstanding Bonds

ChemoMetec issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ChemoMetec AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ChemoMetec bonds can be classified according to their maturity, which is the date when ChemoMetec AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in ChemoMetec Stock

ChemoMetec financial ratios help investors to determine whether ChemoMetec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChemoMetec with respect to the benefits of owning ChemoMetec security.